X-Rx's Corporate Majority Round

X-Rx raised a round of funding on October 01, 2010. Investors include Pharmaceutical Product Development.

X-Rx, dba X-Chem Pharmaceuticals, applies its drug discovery capabilities to the discovery of compounds against therapeutic targets. X-Chem's internal program is to screen targets in stem cell biology…

Articles about X-Rx's Corporate Majority Round: